GO:0002250 adaptive immune response: Immunological Memory Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002250 adaptive immune response is defined as an immune response mediated by cells expressing specific antigen receptors generated through somatic diversification, enabling enhanced secondary responses and immunological memory.
• The process bridges innate sensing and adaptive effector function, with redox regulation and innate-adaptive crosstalk shaping the magnitude and quality of the response.
• Key cellular players include T and B lymphocytes, antigen-presenting cells, and neutrophils that modulate the initiation and resolution of adaptive immunity.
• Adaptive immunity is central to vaccine design, as mRNA vaccine platforms must balance innate and adaptive arms to achieve protective memory.
• Pathogens including PRRSV, BK virus, hepatitis C virus, and Newcastle disease virus have evolved evasion strategies that specifically target adaptive immune mechanisms.
• In tumors, innate immune signals can restart and sustain adaptive immune responses, making this GO term relevant to cancer immunotherapy research.
Description
The adaptive immune response (GO:0002250) is a biological process in which cells expressing somatically diversified antigen receptors mount a specific response that confers immunological memory and an enhanced secondary response upon re-exposure to the same antigen. This process is distinguished from innate immunity by its receptor specificity, clonal selection, and memory formation, and it is regulated through complex crosstalk with innate immune signaling and redox pathways. Understanding GO:0002250 is essential for researchers studying host defense, vaccine development, autoimmunity, and tumor immunology. The adaptive immune response is mediated by T and B lymphocytes and is supported by antigen-presenting cells and innate effectors such as neutrophils, which influence the initiation and resolution of adaptive immunity. Pathogen-specific studies have revealed that viruses including PRRSV, BK virus, and hepatitis C virus engage and evade adaptive immune mechanisms, making this GO term a focal point for infectious disease research. In poultry, adaptive immune responses to Newcastle disease vaccines are a model for understanding vaccine-induced memory. In oncology, innate immune signals can restart adaptive immune responses in tumors, linking GO:0002250 to immunotherapy. This article synthesizes the definition, mechanisms, key genes, disease relevance, and research methods for GO:0002250, with a focus on how CRISPR-based models can be used to dissect this process.
adaptive immune response At A Glance
| GO ID | GO:0002250 |
|---|---|
| GO term | adaptive immune response |
| Ontology | biological_process |
| Synonym | acquired immune response; immune memory response |
| Definition | An immune response mediated by cells expressing specific receptors for antigens produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory) |
| Major function | Antigen-specific recognition, clonal expansion, effector function, and immunological memory |
| Cellular players | T and B lymphocytes, antigen-presenting cells, and innate effectors such as neutrophils |
| Regulatory context | Innate-adaptive crosstalk and redox regulation modulate the response |
| Disease relevance | Viral infections, cancer immunotherapy, and vaccine responses |
What Is GO:0002250?
According to the Gene Ontology, GO:0002250 adaptive immune response is defined as an immune response mediated by cells expressing specific receptors for antigens produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory). In other words, it is the branch of immunity that generates antigen-specific receptors via somatic diversification, selects and expands responsive cell clones, and establishes memory so that later encounters with the same antigen trigger a faster and stronger response. This definition distinguishes adaptive immunity from innate immunity by its receptor specificity and memory capacity, and it encompasses the cellular and molecular events that link innate sensing to adaptive effector function.
Why Is adaptive immune response Important in Cell Biology?
GO:0002250 is important because it defines the mechanistic basis of immunological memory, which underpins vaccine efficacy, pathogen clearance, and long-term protection. Dysregulation of adaptive immunity contributes to chronic viral infections, tumor immune evasion, and failed vaccine responses, and understanding its regulation is essential for rational immunotherapeutic design.
• Provides the mechanistic basis for immunological memory and enhanced secondary responses to antigen.
• Underpins vaccine design, including mRNA vaccines that must balance innate and adaptive immune activation.
• Is targeted by viral evasion strategies in PRRSV, BK virus, and hepatitis C virus infections.
• Is relevant to poultry vaccine responses against Newcastle disease virus.
• Can be restarted by innate immune signals in tumors, linking it to cancer immunotherapy.
• Involves neutrophils that modulate initiation and resolution of adaptive immunity.
• Is regulated by redox and innate-adaptive crosstalk that shape response magnitude and quality.
• Serves as a framework for identifying gene targets via CRISPR knockout, knock-in, and overexpression models.
What Happens During adaptive immune response?
Antigen recognition and innate-adaptive crosstalk
In simple terms: The body first senses danger signals, and this innate sensing helps activate the specific adaptive response.
The adaptive immune response begins when innate immune sensing detects pathogens or danger signals and provides costimulatory and cytokine signals that license adaptive activation. Redox regulation and innate-adaptive immunity interplay shape the magnitude and quality of this transition, ensuring that adaptive responses are initiated in the appropriate context. Neutrophils also participate in this phase by modulating the inflammatory environment that influences subsequent adaptive immunity.
Somatic diversification and antigen receptor generation
In simple terms: Immune cells generate a huge variety of receptors so that some can recognize almost any invader.
A defining feature of GO:0002250 is the production of specific antigen receptors through somatic diversification, which generates a diverse repertoire of T cell receptors and B cell receptors/antibodies. This diversification allows the immune system to recognize a vast array of antigens and is the molecular basis for specificity in the adaptive response.
Clonal selection, expansion, and effector differentiation
In simple terms: The cells that recognize the invader multiply and turn into fighter cells.
Upon antigen recognition, lymphocytes undergo clonal selection and expansion, differentiating into effector cells that mediate pathogen clearance. This phase is influenced by innate immune signals and redox status, which can modulate the efficiency of effector differentiation. In viral infections such as PRRSV, the kinetics and quality of this phase determine the outcome of the adaptive response.
Memory formation and secondary response
In simple terms: Some cells remain as memory cells so the next encounter triggers a faster, stronger response.
The adaptive immune response establishes immunological memory, allowing an enhanced secondary response upon subsequent exposure to the same antigen. This memory component is the basis for vaccine-induced protection, and mRNA vaccine platforms are designed to balance innate and adaptive signals to optimize memory formation. In poultry, adaptive immune responses to Newcastle disease vaccines illustrate the induction of memory in a veterinary context.
Pathogen evasion and modulation of adaptive immunity
In simple terms: Some viruses try to hide from or shut down the specific immune response.
Pathogens have evolved strategies to evade or modulate the adaptive immune response, as documented for PRRSV, BK virus, and hepatitis C virus. These evasion mechanisms can blunt effector function and memory formation, and understanding them is critical for vaccine and antiviral development. In tumors, innate immune signals can restart adaptive immune responses, suggesting that similar restart mechanisms may be harnessed therapeutically.
Key Genes Involved in GO:0002250 adaptive immune response
The following genes and proteins are central to the adaptive immune response (GO:0002250), based on their roles in antigen recognition, somatic diversification, effector function, and memory.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD3D | T cell receptor signaling component | T cell activation and effector function studies |
| CD4 | T helper cell co-receptor | MHC class II-restricted T cell responses |
| CD8A | Cytotoxic T cell co-receptor | MHC class I-restricted killing |
| IGHM | B cell receptor/antibody heavy chain | B cell development and humoral immunity |
| IGKC | Antibody light chain constant region | Antibody production and memory |
| PRDM1 | Plasma cell differentiation regulator | B cell to plasma cell transition |
| XBP1 | Plasma cell secretory program | Antibody secretion |
| AICDA | Somatic hypermutation and class switching | Antibody diversification |
| IL2 | T cell growth factor | Clonal expansion and effector differentiation |
| IFNG | Th1 effector cytokine | Antiviral and antitumor immunity |
| TNF | Proinflammatory cytokine | Effector and memory responses |
| FOXP3 | Regulatory T cell transcription factor | Immune tolerance and regulation |
| BATF | T cell differentiation transcription factor | Effector T cell programming |
| IRF4 | Lymphocyte differentiation regulator | B and T cell fate decisions |
| PRF1 | Cytotoxic granule protein | CD8 T cell and NK cytotoxicity |
| GZMB | Cytotoxic serine protease | Effector killing of infected cells |
| CD27 | Costimulatory receptor | Memory B and T cell generation |
How Is adaptive immune response Regulated?
The adaptive immune response is regulated by innate-adaptive crosstalk and redox regulation, which together shape the initiation, magnitude, and resolution of the response. Innate immune signals can restart adaptive immune responses in tumors, indicating that regulatory checkpoints exist between innate sensing and adaptive activation. mRNA vaccine design explicitly aims to tailor innate signals to balance and optimize adaptive immunity. Neutrophils contribute to the regulatory environment that influences adaptive immune outcomes.
adaptive immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AICDA | Antibody diversification defects | Knockout in B cell lines |
| FOXP3 | Immune dysregulation | Point mutation knock-in |
| IFNG | Impaired antiviral immunity | Overexpression and knockout |
| PRF1 | Cytotoxicity defects | Knockout in T cell models |
| CD27 | Memory B cell deficiency | Knock-in reporter |
Viral infections and immune evasion
Adaptive immune responses are central to controlling viral infections, but viruses such as PRRSV, BK virus, and hepatitis C virus have evolved evasion strategies that subvert adaptive immunity. These evasion mechanisms can lead to chronic infection and complicate vaccine development. Understanding how adaptive immunity is modulated in these contexts is essential for antiviral strategies.
Cancer immunotherapy
In tumors, innate immune signals can restart adaptive immune responses, linking GO:0002250 to cancer immunotherapy. This crosstalk suggests that therapeutic activation of innate pathways may reinvigorate adaptive antitumor immunity. Research into this process may inform combination immunotherapies.
Vaccine development
Vaccines depend on the induction of adaptive immunity and immunological memory, and mRNA vaccine platforms are designed to balance innate and adaptive responses. In poultry, adaptive immune responses to Newcastle disease vaccines provide a model for vaccine-induced protection. Understanding the regulatory balance is key to optimizing vaccine efficacy.
From adaptive immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for T cell activation? | CRISPR knockout in primary T cells or Jurkat cells |
| Does a specific point mutation alter cytokine signaling? | Point mutation knock-in in immune cell lines |
| Can a reporter track memory B cell formation? | Tagged knock-in of memory markers |
| Does overexpression of a cytokine enhance effector function? | Overexpression in primary lymphocytes |
| Which genes regulate vaccine-induced memory? | CRISPR library screening in vaccine models |
| How does innate signaling restart adaptive immunity in tumors? | Knockout and overexpression in tumor-immune co-cultures |
How to Study the adaptive immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Immune cell subsets and activation markers | T/B cell phenotyping |
| ELISPOT | Antigen-specific cytokine secretion | Vaccine and infection studies |
| CRISPR knockout screening | Gene requirement for immune function | Host factor discovery |
| RNA-seq | Transcriptional programs | Effector and memory differentiation |
| Single-cell RNA-seq | Cellular heterogeneity | Tumor-immune crosstalk |
| Antibody neutralization assays | Humoral immunity | Viral infection studies |
| Reporter knock-in imaging | Memory cell tracking | Vaccine response models |
Flow cytometry and immunophenotyping
Flow cytometry is used to identify and quantify T and B cell subsets, memory populations, and effector molecules during adaptive immune responses. This method is essential for tracking clonal expansion and differentiation in vaccine and infection studies.
Cytokine and antibody profiling
Measuring cytokines such as IFNG and TNF, and antigen-specific antibodies, provides functional readouts of adaptive immunity. These assays are widely used in viral infection and vaccine research.
CRISPR screening and functional genomics
CRISPR library screening enables unbiased discovery of genes that regulate adaptive immune responses, including those controlling memory formation and effector function. This approach is particularly useful for identifying host factors in viral evasion and tumor immunity.
Single-cell and transcriptomic analysis
Single-cell RNA sequencing and transcriptomic profiling reveal heterogeneity in adaptive immune cell populations and their regulatory programs. These methods help map the gene networks underlying GO:0002250 in health and disease.
How CRISPR Can Be Used to Study GO:0002250 adaptive immune response
Knockout
CRISPR knockout of candidate genes in immune cell lines or primary cells can determine whether a gene is required for adaptive immune functions such as T cell activation, cytokine production, or memory formation. This approach is widely used to dissect host factors in viral evasion and tumor immunity.
Point Mutation
Point mutation knock-in allows researchers to model specific amino acid changes that may alter signaling, receptor specificity, or effector function in adaptive immune cells. Such models are valuable for studying disease-associated variants in immune genes.
Knock-in
Tagged knock-in of immune markers enables tracking of memory and effector populations in vivo and in vitro. This strategy is useful for studying vaccine-induced memory and tumor-immune interactions.
Overexpression
Overexpression of cytokines, transcription factors, or receptors can enhance or perturb adaptive immune responses, providing gain-of-function insights. This approach complements knockout studies in defining gene function.
How EDITGENE Supports adaptive immune response Research
Researchers studying adaptive immune response-related genes often need to determine whether a candidate gene is causally involved in antigen recognition, effector function, or memory formation, and CRISPR-based models provide a direct way to test these hypotheses. EDITGENE offers a suite of services to support such studies, from knockout to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for adaptive immune response research.
Frequently Asked Questions About adaptive immune response
What is GO:0002250 adaptive immune response?
GO:0002250 is a Gene Ontology biological process defined as an immune response mediated by cells expressing specific antigen receptors generated through somatic diversification, enabling enhanced secondary responses and immunological memory.
What genes are involved in adaptive immune response?
Key genes include CD3D, CD4, CD8A, IGHM, IGKC, PRDM1, XBP1, AICDA, IL2, IFNG, TNF, FOXP3, BATF, IRF4, PRF1, GZMB, and CD27, based on their roles in antigen recognition, effector function, and memory.
How is adaptive immunity different from innate immunity?
Adaptive immunity uses somatically diversified antigen-specific receptors and forms memory, whereas innate immunity relies on germline-encoded pattern recognition and lacks immunological memory.
What is the role of innate-adaptive crosstalk in immune response?
Innate immune sensing provides signals that license and shape adaptive activation, and redox regulation modulates this interplay.
How do viruses evade adaptive immune responses?
Viruses such as PRRSV, BK virus, and hepatitis C virus have evolved strategies to evade or modulate adaptive immunity, leading to chronic infection.
Can adaptive immunity be restarted in tumors?
Yes, innate immune signals can restart adaptive immune responses in tumors, which is relevant to cancer immunotherapy.
How are mRNA vaccines designed to balance innate and adaptive immunity?
mRNA vaccine platforms are tailored to balance innate and adaptive signals to optimize protective memory.
What is the role of neutrophils in adaptive immunity?
Neutrophils modulate the inflammatory environment and influence the initiation and resolution of adaptive immune responses.
What research methods are used to study adaptive immune response?
Flow cytometry, ELISPOT, CRISPR screening, RNA-seq, single-cell RNA-seq, and antibody neutralization assays are commonly used.
How can CRISPR models help study GO:0002250?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes involved in antigen recognition, effector function, and memory.
Conclusion
GO:0002250 adaptive immune response is a central biological process that governs antigen-specific immunity and immunological memory, with broad relevance to infectious disease, cancer, and vaccine development. Understanding its mechanisms, key genes, and regulation provides a foundation for therapeutic and diagnostic innovation. CRISPR-based models and functional genomics approaches are powerful tools for dissecting this process and identifying new targets.
References
- 1. Sun L et al.. 2020. Innate-adaptive immunity interplay and redox regulation in immune response.. Redox Biol 37:101759 PMID: 33086106
- 2. Cai H et al.. 2023. Progress in PRRSV Infection and Adaptive Immune Response Mechanisms.. Viruses 15(7) PMID: 37515130
- 3. Fallatah DI et al.. 2025. Adaptive immune response and evasion strategies of BK virus.. Transplant Rev (Orlando) 39(4):100959 PMID: 40829212
- 4. Kemming J et al.. 2020. Adaptive Immune Response against Hepatitis C Virus.. Int J Mol Sci 21(16) PMID: 32781731
- 5. Liew PX et al.. 2019. The Neutrophil's Role During Health and Disease.. Physiol Rev 99(2):1223-1248 PMID: 30758246
- 6. Li WS et al.. 2023. Innate immune response restarts adaptive immune response in tumors.. Front Immunol 14:1260705 PMID: 37781382
- 7. Chai Y et al.. 2025. Adaptive immune response of poultry to Newcastle disease vaccines.. Arch Virol 171(1):14 PMID: 41348231
- 8. Linares-Fernández S et al.. 2020. Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response.. Trends Mol Med 26(3):311-323 PMID: 31699497
